RxDoctor Payments Data

Wolfgang Leesch, MD

Vascular Neurology · Newport News, VANPI 1255453320

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $17,414 of the $26,106 with a category attached, or 66.7%. 19 manufacturers reported payments, led by Penumbra, Inc. at 39.5% of the total.

$26,106in general payments, 2019–2025

Across 344 payments — averaging $75.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$10K
  • Imperative Care, Inc$6K
  • Medtronic$5K
  • Stryker$2K
  • Medical Device Business Services, Inc.$993
  • Johnson & Johnson$993
  • plus $2K from 13 others

What the payments were for

  • Travel & lodging$8,66833%
  • Food & beverage$17,41467%
  • Education$200%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular neurology providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$225,631
Medicare patients
185
Services billed
1,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor69$41,130
ClopidogrelClopidogrel Bisulfate126$1,116
Atorvastatin Calcium34$231

Paid to pharmacies, not to this prescriber.

Other vascular neurology in Newport News

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →